REN and Hypertension: This systematic review evaluated the comparative efficacy of direct renin inhibitors, primarily aliskiren, versus angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARBs) in the management of hypertension across varied patient populations.